Share
The Senate voted 52-43 to reject a Congressional Review Act resolution led by U.S. Sen. Mark Warner (D-VA) to protect Americans with preexisting conditions.
Share
U.S. Sen. Mark Warner (D-VA) is pressing Facebook CEO Mark Zuckerberg to reverse a policy allowing politicians and elected officials to run demonstrably false advertisements on the platform.
Share
Sens. Mark Warner (D-VA), Amy Klobuchar (D-MN), and Ron Wyden (D-OR), asked Wednesday for unanimous consent for the immediate consideration of legislation to stop foreign interference in our elections.
Share
U.S. Sen. Mark Warner (D-VA) has urged the U.S. Securities and Exchange Commission to require companies to disclose more information regarding their investment in workers.
Share
U.S. Sen. Mark Warner (D-VA) took to the Senate floor today to highlight a number of Virginians with pre-existing conditions who will be affected if the Senate neglects to overturn a Trump Administration waiver rule.
Share
U.S. Sen. Mark Warner (D-VA) said today that he was optimistic about the chances of passing bipartisan anti-money laundering legislation this Congress.
Share
U.S. Sen. Mark Warner today introduced the Syrian Allies Protection Act, which would make U.S. visas available to Kurdish Syrians who worked directly with the U.S. armed forces in Syria.
Share
U.S. Sens. Mark Warner and Tim Kaine (both D-VA) requested information from Virginia’s insurance commission on how the Trump Administration’s push for “junk” health insurance plans is affecting protections for Virginians with preexisting conditions.
Share
U.S. Sen. Mark Warner (D-VA) expressed his frustration this week over repeated delays and inaction by the Department of Justice (DOJ) regarding the implementation of the Ashanti Alert Act.
Share
U.S. Sen. Mark Warner (D-VA)is urging HHS and the Centers for Medicare & Medicaid Services to protect individuals with preexisting conditions.
Local news is in “serious jeopardy,” according to experts. Pitch in and help AFP continue to deliver news to the Valley, Virginia and beyond.